|
Market Closed -
Nasdaq
21:00:00 01/09/2026 BST
|
5-day change | 1st Jan Change | ||
| 22.26 USD | +1.09% |
|
+1.18% | - |
| 09-01 | Jefferies Initiates Latigo Biotherapeutics at Buy With $50 Price Target | MT |
| 09-01 | Leerink Partners Initiates Latigo Biotherapeutics at Outperform With $36 Price Target | MT |
| Market Cap | 1.39B 1.2B 1.13B 1.03B 1.94B 132B 1.95B 13.39B 5.2B 67.21B 5.23B 5.11B 223B | P/E 2026 * |
-9.18x | P/E 2027 * | -9.62x |
|---|---|---|---|---|---|
| Enterprise Value | 1.03B 886M 834M 760M 1.43B 97.56B 1.44B 9.88B 3.84B 49.6B 3.86B 3.77B 165B | EV / Sales 2026 * |
-
| EV / Sales 2027 * | - |
| Free-Float |
-
| Yield 2026 * |
-
| Yield 2027 * | - |
| 1 day | +1.09% | ||
| 1 week | +1.18% | ||
| Current month | +1.09% |
| 1 week | 21.26 |  | 25.93 |
| 1 month | 17.22 | | 25.93 |
| Current year | 17.22 | | 25.93 |
| 1 year | 17.22 | | 25.93 |
| 3 years | 17.22 | | 25.93 |
| 5 years | 17.22 | | 25.93 |
| 10 years | 17.22 | | 25.93 |
| Manager | Title | Age | Since |
|---|---|---|---|
Nima Farzan
CEO | Chief Executive Officer | 50 | 21/07/2024 |
| Director of Finance/CFO | 39 | 31/01/2026 | |
Cynthia Voong
CTO | Chief Tech/Sci/R&D Officer | - | 31/07/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Nima Farzan
BRD | Director/Board Member | 50 | 21/07/2024 |
Timothy Walbert
CHM | Chairman | 59 | 30/09/2024 |
Sara Bonstein
BRD | Director/Board Member | 45 | 31/03/2026 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 10/08/26 | Westlake Biopartners LLC
| Conversion | Company | 25,390,610 | 40.1509% | |
| 10/08/26 | 5AM Venture Management LLC
| Conversion | Company | 14,651,924 | 23.1695% | |
| 10/08/26 | Foresite Capital Management LLC
| Conversion | Company | 18,222,656 | 28.8160% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | - | - |
| Net income | -133M -115M -108M -98.26M -185M -12.61B -186M -1.28B -496M -6.41B -499M -488M -21.27B | -160M -138M -130M -119M -223M -15.24B -225M -1.54B -599M -7.75B -603M -589M -25.71B |
| Net Debt | -365M -315M -296M -270M -507M -34.64B -511M -3.51B -1.36B -17.61B -1.37B -1.34B -58.45B | -513M -442M -416M -379M -712M -48.67B -717M -4.93B -1.91B -24.75B -1.92B -1.88B -82.13B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 01/09/26 | US$22.26 | +1.09% | 286,608 |
| 31/08/26 | US$22.02 | -9.12% | 155,037 |
| 28/08/26 | US$24.23 | -3.08% | 217,741 |
| 27/08/26 | US$25.00 | +3.61% | 235,659 |
| 26/08/26 | US$24.13 | +6.91% | 137,935 |
Sell
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
22.26USD
Average target price
61.50USD
Spread / Average Target
+176.28%
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- LTGO Stock
Select your edition
All financial news and data tailored to specific country editions
